Insider · CIK 0001655016

Fox Jonathan C

Reports to the SEC for 3 companies · BOULDER, CO

sec.gov

Transactions

Companies

Filings

CIK

0001655016

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	EWTXEdgewise Therapeutics, Inc.A Award	Director	AAward	+308 sh	—	—	25,141
2026-07-01	EWTXEdgewise Therapeutics, Inc.A Award	Director	AAward	+319 sh	—	—	24,833
2026-06-05	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.4K sh	—	—	16,377
2026-04-01	EWTXEdgewise Therapeutics, Inc.A Award	Director	AAward	+339 sh	—	—	24,514
2026-01-02	EWTXEdgewise Therapeutics, Inc.A Award	Director	AAward	+473 sh	—	—	24,175
2025-11-11	EWTXEdgewise Therapeutics, Inc.P Purchase	Director	PPurchase	+10.7K sh	$18.64	+$199K	23,702
2025-10-01	EWTXEdgewise Therapeutics, Inc.A Award	Director	AAward	+728 sh	—	—	13,002
2025-07-01	EWTXEdgewise Therapeutics, Inc.A Award	Director	AAward	+858 sh	—	—	12,274
2025-06-16	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-04-01	EWTXEdgewise Therapeutics, Inc.A Award	Director	AAward	+559 sh	—	—	11,416
2024-06-10	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.6K sh	—	—	20,594
2023-12-26	EWTXEdgewise Therapeutics, Inc.P Purchase	Director	PPurchase	+10.9K sh	$9.30	+$101K	10,857
2023-06-12	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.1K sh	—	—	22,123
2023-03-03	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+43.7K sh	—	—	43,731
2021-01-26	Eidos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−70K sh	—	—	0
2021-01-26	Eidos Therapeutics, Inc.U Disposition from Tender	See Remarks	UDisposition from Tender	−380K sh	—	—	0
2020-12-28	Eidos Therapeutics, Inc.G Gift	See Remarks	GGift	−500 sh	—	—	380,467
2020-09-17	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−5,767 sh	$50.16	−$289K	377,673
2020-09-16	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−3,122 sh	$50.16	−$157K	383,440
2020-09-15	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−1,000 sh	$50.06	−$50.1K	386,562
2020-09-14	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−111 sh	$50.00	−$5,550	387,562
2020-07-07	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−5,000 sh	$50.00	−$250K	387,673
2020-06-29	Eidos Therapeutics, Inc.J Other	See Remarks	JOther	+1,088 sh	—	—	392,673
2020-06-03	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−5,000 sh	$50.00	−$250K	391,585
2020-06-02	Eidos Therapeutics, Inc.G Gift	See Remarks	GGift	−1,020 sh	—	—	396,585
2020-06-01	Eidos Therapeutics, Inc.G Gift	See Remarks	GGift	−1,020 sh	—	—	397,605
2020-05-31	Eidos Therapeutics, Inc.A Award	See Remarks	AAward	+444 sh	$41.57	+$18.5K	3,294
2020-05-28	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−5,000 sh	$50.00	−$250K	398,625
2020-04-24	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−2,153 sh	$50.00	−$108K	403,625
2020-04-23	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−2,847 sh	$50.00	−$142K	405,778
2020-03-02	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−10K sh	$51.57	−$516K	408,625
2020-02-13	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−10K sh	$54.00	−$540K	418,625
2020-02-04	Eidos Therapeutics, Inc.G Gift	See Remarks	GGift	−1,632 sh	—	—	428,625
2020-01-15	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−3,580 sh	$55.00	−$197K	430,257
2020-01-14	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−6,420 sh	$55.01	−$353K	433,837
2019-12-30	Eidos Therapeutics, Inc.G Gift	See Remarks	GGift	−100 sh	—	—	440,257
2019-12-26	Eidos Therapeutics, Inc.G Gift	See Remarks	GGift	−170 sh	—	—	440,357
2019-12-04	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−10K sh	$58.90	−$589K	440,527
2019-11-26	Eidos Therapeutics, Inc.G Gift	See Remarks	GGift	−1,000 sh	—	—	450,527
2019-11-25	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−10K sh	$56.52	−$565K	451,527
2019-11-21	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−10K sh	$55.11	−$551K	461,527
2019-11-18	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−10K sh	$50.26	−$503K	471,527
2019-11-15	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−900 sh	$46.45	−$41.8K	481,527
2019-11-15	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−2,100 sh	$45.51	−$95.6K	482,427
2019-11-15	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−2,000 sh	$44.88	−$89.8K	484,527
2019-10-15	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−4,998 sh	$36.16	−$181K	486,529
2019-10-15	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−2 sh	$36.71	−$73.42	486,527
2019-09-16	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−5,000 sh	$45.74	−$229K	491,527
2019-08-15	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−2,220 sh	$38.36	−$85.2K	499,307
2019-08-15	Eidos Therapeutics, Inc.S Sale	See Remarks	SSale	−2,780 sh	$39.01	−$108K	496,527

Recent filings

Accepted (ET)
Oct 24
Fox Jonathan C0001655016-26-000006
SEC(opens sec.gov)
Jul 14
Fox Jonathan C0001655016-26-000004
SEC(opens sec.gov)
Jun 164
Fox Jonathan C0001655016-26-000003
SEC(opens sec.gov)
Apr 34
Fox Jonathan C0001655016-26-000002
SEC(opens sec.gov)
Jan 54
Fox Jonathan C0001655016-26-000001
SEC(opens sec.gov)
Nov 134
Fox Jonathan C0001655016-25-000007
SEC(opens sec.gov)
Oct 24
Fox Jonathan C0001655016-25-000004
SEC(opens sec.gov)
Jul 24
Fox Jonathan C0001562180-25-005233
SEC(opens sec.gov)
Jun 184
Fox Jonathan C0001562180-25-004959
SEC(opens sec.gov)
Apr 34
Fox Jonathan C0001562180-25-002992
SEC(opens sec.gov)
Jun 124
Fox Jonathan C0001562180-24-005021
SEC(opens sec.gov)
Dec 284
Fox Jonathan C0001562180-23-008573
SEC(opens sec.gov)
Jun 144
Fox Jonathan C0001562180-23-005178
SEC(opens sec.gov)
Mar 74
Fox Jonathan C0001562180-23-002584
SEC(opens sec.gov)
Jan 284
Fox Jonathan C0000899243-21-003671
SEC(opens sec.gov)
Sep 184
Fox Jonathan C0000899243-20-025694
SEC(opens sec.gov)
Sep 164
Fox Jonathan C0000899243-20-025364
SEC(opens sec.gov)

Companies

Address

C/O EDGEWISE THERAPEUTICS, INC. 1715 38TH STREET

BOULDER, CO, 80301